Literature DB >> 944786

Diester derivatives as apomorphine prodrugs.

R J Borgman, R J Baldessarini, K G Walton.   

Abstract

A series of diesters of apomorphine was synthesized to serve as prodrugs. They were converted in vivo to free apomorphine, which could be detected in the brain. Stereotyped gnawing behavior and unilateral rotation similar to that produced by apomorphine were induced by all of the diesters but the time course of action of the latter was prolonged. The duration of action generally increased with the size of the ester substituent and appeared to correlate inversely with the rate of hydrolysis of the esters by liver extracts. It is concluded that the diesters serve as prodrugs of apomorphine and their prolonged duration is partly explained by a decreasing rate of hydrolysis attributable to increased steric hindrance at the acyl carbon atoms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944786     DOI: 10.1021/jm00227a026

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.

Authors:  R J Baldessarini; N S Kula; K G Walton
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

2.  Evaluation of mono- and dibenzoyl esters of dopamine as potential pro-drugs for dopamine in the central nervous system.

Authors:  S M Tejani-Butt; M Hauptmann; A D'Mello; A Frazer; J M Marcoccia; D J Brunswick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

3.  Structure-Functional-Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands.

Authors:  Hyejin Park; Aarti N Urs; Joseph Zimmerman; Chuan Liu; Qiu Wang; Nikhil M Urs
Journal:  ACS Med Chem Lett       Date:  2020-01-06       Impact factor: 4.345

4.  Improvement of the oral bioavailability of the selective dopamine agonist N-0437 in rats: the in vitro and in vivo activity of eight ester prodrugs.

Authors:  I den Daas; P G Tepper; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

Review 5.  Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease.

Authors:  Nrupa Borkar; Huiling Mu; René Holm
Journal:  Asian J Pharm Sci       Date:  2017-12-06       Impact factor: 6.598

Review 6.  Antiparkinson prodrugs.

Authors:  Antonio Di Stefano; Piera Sozio; Laura Serafina Cerasa
Journal:  Molecules       Date:  2008-01-16       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.